questionsmedicales.fr
Disciplines et activités comportementales
Psychothérapie
Thérapie socio-environnementale
Thérapie socio-environnementale : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Thérapie socio-environnementale : Questions médicales les plus fréquentes",
"headline": "Thérapie socio-environnementale : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Thérapie socio-environnementale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-18",
"dateModified": "2025-05-13",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Thérapie socio-environnementale"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Psychothérapie",
"url": "https://questionsmedicales.fr/mesh/D011613",
"about": {
"@type": "MedicalCondition",
"name": "Psychothérapie",
"code": {
"@type": "MedicalCode",
"code": "D011613",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Psychothérapie par le milieu",
"alternateName": "Milieu Therapy",
"url": "https://questionsmedicales.fr/mesh/D008884",
"about": {
"@type": "MedicalCondition",
"name": "Psychothérapie par le milieu",
"code": {
"@type": "MedicalCode",
"code": "D008884",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.864.392"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Communauté thérapeutique",
"alternateName": "Therapeutic Community",
"url": "https://questionsmedicales.fr/mesh/D013808",
"about": {
"@type": "MedicalCondition",
"name": "Communauté thérapeutique",
"code": {
"@type": "MedicalCode",
"code": "D013808",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.864.392.701"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Psychothérapie de groupe",
"alternateName": "Psychotherapy, Group",
"url": "https://questionsmedicales.fr/mesh/D011615",
"about": {
"@type": "MedicalCondition",
"name": "Psychothérapie de groupe",
"code": {
"@type": "MedicalCode",
"code": "D011615",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.864.581"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Thérapie de couple",
"alternateName": "Couples Therapy",
"url": "https://questionsmedicales.fr/mesh/D019546",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie de couple",
"code": {
"@type": "MedicalCode",
"code": "D019546",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.864.581.136"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Thérapie conjugale",
"alternateName": "Marital Therapy",
"url": "https://questionsmedicales.fr/mesh/D008388",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie conjugale",
"code": {
"@type": "MedicalCode",
"code": "D008388",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.864.581.136.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Thérapie conjugale",
"alternateName": "Marital Therapy",
"url": "https://questionsmedicales.fr/mesh/D008388",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie conjugale",
"code": {
"@type": "MedicalCode",
"code": "D008388",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.864.581.136.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Thérapie familiale",
"alternateName": "Family Therapy",
"url": "https://questionsmedicales.fr/mesh/D005196",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie familiale",
"code": {
"@type": "MedicalCode",
"code": "D005196",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.864.581.273"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Psychodrame",
"alternateName": "Psychodrama",
"url": "https://questionsmedicales.fr/mesh/D011577",
"about": {
"@type": "MedicalCondition",
"name": "Psychodrame",
"code": {
"@type": "MedicalCode",
"code": "D011577",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.864.581.679"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Jeu de rôle",
"alternateName": "Role Playing",
"url": "https://questionsmedicales.fr/mesh/D012381",
"about": {
"@type": "MedicalCondition",
"name": "Jeu de rôle",
"code": {
"@type": "MedicalCode",
"code": "D012381",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.864.581.679.653"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Jeu de rôle",
"alternateName": "Role Playing",
"url": "https://questionsmedicales.fr/mesh/D012381",
"about": {
"@type": "MedicalCondition",
"name": "Jeu de rôle",
"code": {
"@type": "MedicalCode",
"code": "D012381",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.864.581.679.653"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Groupes d'apprentissage en commun",
"alternateName": "Sensitivity Training Groups",
"url": "https://questionsmedicales.fr/mesh/D012681",
"about": {
"@type": "MedicalCondition",
"name": "Groupes d'apprentissage en commun",
"code": {
"@type": "MedicalCode",
"code": "D012681",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.864.581.813"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Traitement résidentiel",
"alternateName": "Residential Treatment",
"url": "https://questionsmedicales.fr/mesh/D012114",
"about": {
"@type": "MedicalCondition",
"name": "Traitement résidentiel",
"code": {
"@type": "MedicalCode",
"code": "D012114",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.864.696"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Thérapie socio-environnementale",
"alternateName": "Socioenvironmental Therapy",
"code": {
"@type": "MedicalCode",
"code": "D012960",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Terri A deRoon-Cassini",
"url": "https://questionsmedicales.fr/author/Terri%20A%20deRoon-Cassini",
"affiliation": {
"@type": "Organization",
"name": "Medical College of Wisconsin, USA."
}
},
{
"@type": "Person",
"name": "Guangrong Zheng",
"url": "https://questionsmedicales.fr/author/Guangrong%20Zheng",
"affiliation": {
"@type": "Organization",
"name": "College of Pharmacy, University of Florida, Gainesville, FL, USA."
}
},
{
"@type": "Person",
"name": "Vargas Del Río David",
"url": "https://questionsmedicales.fr/author/Vargas%20Del%20R%C3%ADo%20David",
"affiliation": {
"@type": "Organization",
"name": "Department of Habitat and Human Development. Periférico Sur Manuel Gómez Morín 8585, Instituto Tecnológico y de Estudios Superiores de Occidente, Santa María Tequepexpan, San Pedro Tlaquepaque, Jal 45604, Mexico."
}
},
{
"@type": "Person",
"name": "Brenner Ludger",
"url": "https://questionsmedicales.fr/author/Brenner%20Ludger",
"affiliation": {
"@type": "Organization",
"name": "Unidad Iztapalapa, Department of Sociology, Universidad Autónoma Metropolitana, Avenida San Rafael Atlixco 186, Mexico City 09340, Mexico."
}
},
{
"@type": "Person",
"name": "Natalia Hanazaki",
"url": "https://questionsmedicales.fr/author/Natalia%20Hanazaki",
"affiliation": {
"@type": "Organization",
"name": "Departamento de Ecologia E Zoologia, Centro de Ciências Biológicas, Universidade Federal de Santa Catarina, Campus Universitário S/N, Florianópolis, SC, 88040-900, Brazil. natalia.hanazaki@ufsc.br."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Bullous pemphigoid induced by IgG targeting type XVII collagen non-NC16A/NC15A extracellular domains is driven by Fc gamma receptor- and complement-mediated effector mechanisms and is ameliorated by neonatal Fc receptor blockade.",
"datePublished": "2023-11-06",
"url": "https://questionsmedicales.fr/article/37929639",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/path.6220"
}
},
{
"@type": "ScholarlyArticle",
"name": "Gene expression profiling and multiplex immunofluorescence analysis of bullous pemphigoid immune-related adverse event reveal upregulation of toll-like receptor 4/complement-induced innate immune response and increased density of T",
"datePublished": "2023-05-07",
"url": "https://questionsmedicales.fr/article/37150813",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/cup.14442"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Greater Increase in Complement C5a Receptor 1 Level at Onset and a Smaller Decrease in Immunoglobulin G Level after Recovery in Severer Coronavirus Disease 2019 Patients: A New Analysis of Existing Data with a New Two-Tailed",
"datePublished": "2023-08-28",
"url": "https://questionsmedicales.fr/article/37759576",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/biology12091176"
}
},
{
"@type": "ScholarlyArticle",
"name": "Clinical significance of low pre-transplant donor specific antibodies (DSA) in living donor kidney recipients with negative complement-dependent cytotoxicity crossmatches (CDCXM), and negative flow cytometry crossmatches (FLXM) - A single-center experience.",
"datePublished": "2022-07-19",
"url": "https://questionsmedicales.fr/article/35868613",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.trim.2022.101672"
}
},
{
"@type": "ScholarlyArticle",
"name": "Statement complementing the EFSA Scientific Opinion on application (EFSA-GMO-NL-2015-126) for authorisation of food and feed containing, consisting of and produced from genetically modified soybean MON 87705 × MON 87708 × MON 89788.",
"datePublished": "2024-10-28",
"url": "https://questionsmedicales.fr/article/39469434",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2903/j.efsa.2024.9061"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Disciplines et activités comportementales",
"item": "https://questionsmedicales.fr/mesh/D004191"
},
{
"@type": "ListItem",
"position": 3,
"name": "Psychothérapie",
"item": "https://questionsmedicales.fr/mesh/D011613"
},
{
"@type": "ListItem",
"position": 4,
"name": "Thérapie socio-environnementale",
"item": "https://questionsmedicales.fr/mesh/D012960"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Thérapie socio-environnementale - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Thérapie socio-environnementale",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-17",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Thérapie socio-environnementale",
"description": "Comment évaluer l'impact de l'environnement sur la santé ?\nQuels outils sont utilisés pour le diagnostic ?\nQuels professionnels participent au diagnostic ?\nComment identifier les besoins socio-environnementaux ?\nQuelles échelles mesurent le bien-être social ?",
"url": "https://questionsmedicales.fr/mesh/D012960?mesh_terms=Complement+C5&page=172#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Thérapie socio-environnementale",
"description": "Quels symptômes indiquent un besoin de thérapie socio-environnementale ?\nComment l'environnement influence-t-il les symptômes ?\nQuels signes de détresse sociale sont observables ?\nLes symptômes varient-ils selon l'âge ?\nQuels symptômes physiques peuvent être liés à des facteurs sociaux ?",
"url": "https://questionsmedicales.fr/mesh/D012960?mesh_terms=Complement+C5&page=172#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Thérapie socio-environnementale",
"description": "Comment prévenir les problèmes socio-environnementaux ?\nQuels programmes de prévention existent ?\nQuel rôle joue la communauté dans la prévention ?\nComment évaluer l'efficacité des mesures préventives ?\nQuels facteurs de risque peuvent être ciblés ?",
"url": "https://questionsmedicales.fr/mesh/D012960?mesh_terms=Complement+C5&page=172#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Thérapie socio-environnementale",
"description": "Quels types de traitements sont offerts ?\nComment la thérapie de groupe aide-t-elle ?\nQuel rôle joue le counseling individuel ?\nComment les interventions communautaires sont-elles mises en œuvre ?\nQuels résultats attendus des traitements socio-environnementaux ?",
"url": "https://questionsmedicales.fr/mesh/D012960?mesh_terms=Complement+C5&page=172#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Thérapie socio-environnementale",
"description": "Quelles complications peuvent survenir sans traitement ?\nComment les complications affectent-elles la qualité de vie ?\nQuels impacts sur la santé physique peuvent être observés ?\nLes complications sont-elles réversibles ?\nComment prévenir les complications à long terme ?",
"url": "https://questionsmedicales.fr/mesh/D012960?mesh_terms=Complement+C5&page=172#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Thérapie socio-environnementale",
"description": "Quels facteurs de risque socio-environnementaux existent ?\nComment le stress environnemental influence-t-il la santé ?\nQuel rôle joue le soutien social dans la santé ?\nLes antécédents familiaux influencent-ils les risques ?\nComment l'accès aux ressources affecte-t-il la santé ?",
"url": "https://questionsmedicales.fr/mesh/D012960?mesh_terms=Complement+C5&page=172#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer l'impact de l'environnement sur la santé ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'évaluation se fait par des questionnaires et des entretiens sur les conditions de vie."
}
},
{
"@type": "Question",
"name": "Quels outils sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des échelles de mesure et des outils d'évaluation psychosociale sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels professionnels participent au diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Psychologues, travailleurs sociaux et médecins collaborent pour le diagnostic."
}
},
{
"@type": "Question",
"name": "Comment identifier les besoins socio-environnementaux ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les besoins sont identifiés par des entretiens et des observations sur le terrain."
}
},
{
"@type": "Question",
"name": "Quelles échelles mesurent le bien-être social ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des échelles comme le SWLS (Satisfaction With Life Scale) sont utilisées."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un besoin de thérapie socio-environnementale ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Symptômes de stress, d'anxiété, d'isolement social ou de dépression peuvent indiquer un besoin."
}
},
{
"@type": "Question",
"name": "Comment l'environnement influence-t-il les symptômes ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un environnement stressant peut aggraver les symptômes psychologiques et physiques."
}
},
{
"@type": "Question",
"name": "Quels signes de détresse sociale sont observables ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Isolement, conflits familiaux et difficultés relationnelles sont des signes de détresse."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de l'âge et des expériences de vie."
}
},
{
"@type": "Question",
"name": "Quels symptômes physiques peuvent être liés à des facteurs sociaux ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue, douleurs chroniques et troubles du sommeil peuvent être liés à des facteurs sociaux."
}
},
{
"@type": "Question",
"name": "Comment prévenir les problèmes socio-environnementaux ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par l'éducation, le soutien communautaire et l'amélioration des conditions de vie."
}
},
{
"@type": "Question",
"name": "Quels programmes de prévention existent ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des programmes de sensibilisation et des ateliers de compétences sociales sont disponibles."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la communauté dans la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "La communauté peut offrir un soutien, des ressources et des activités pour renforcer les liens."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'efficacité des mesures préventives ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité est évaluée par des études de suivi et des retours d'expérience des participants."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque peuvent être ciblés ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs comme l'isolement social et le stress environnemental peuvent être ciblés."
}
},
{
"@type": "Question",
"name": "Quels types de traitements sont offerts ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la thérapie de groupe, le counseling et des interventions communautaires."
}
},
{
"@type": "Question",
"name": "Comment la thérapie de groupe aide-t-elle ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle favorise le soutien social et l'échange d'expériences entre participants."
}
},
{
"@type": "Question",
"name": "Quel rôle joue le counseling individuel ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le counseling aide à identifier des stratégies personnelles pour faire face aux défis."
}
},
{
"@type": "Question",
"name": "Comment les interventions communautaires sont-elles mises en œuvre ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont mises en œuvre par des programmes de sensibilisation et des activités de groupe."
}
},
{
"@type": "Question",
"name": "Quels résultats attendus des traitements socio-environnementaux ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Amélioration du bien-être, réduction des symptômes et renforcement des liens sociaux."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir sans traitement ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Sans traitement, des complications comme la dépression chronique et l'isolement peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles la qualité de vie ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent réduire la qualité de vie, affecter les relations et la santé physique."
}
},
{
"@type": "Question",
"name": "Quels impacts sur la santé physique peuvent être observés ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles cardiovasculaires et des problèmes immunitaires peuvent être exacerbés."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement approprié et un soutien."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications à long terme ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par un suivi régulier et des interventions précoces adaptées."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque socio-environnementaux existent ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Isolement social, pauvreté et conditions de vie précaires sont des facteurs de risque."
}
},
{
"@type": "Question",
"name": "Comment le stress environnemental influence-t-il la santé ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress environnemental peut aggraver les troubles mentaux et physiques."
}
},
{
"@type": "Question",
"name": "Quel rôle joue le soutien social dans la santé ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un bon soutien social réduit le risque de troubles mentaux et améliore le bien-être."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux influencent-ils les risques ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de troubles mentaux augmentent le risque individuel."
}
},
{
"@type": "Question",
"name": "Comment l'accès aux ressources affecte-t-il la santé ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un accès limité aux ressources augmente le risque de problèmes de santé physique et mentale."
}
}
]
}
]
}
Bullous pemphigoid (BP) is an autoimmune blistering disease characterized by autoantibodies targeting type XVII collagen (Col17) with the noncollagenous 16A (NC16A) ectodomain representing the immunod...
Immune checkpoint inhibitor (ICI)-based cancer therapies cause a variety of cutaneous immune-related adverse events (irAEs) including immunobullous skin eruptions like bullous pemphigoid (BP). However...
BP-irAE (n = 8) and de novo BP control (n = 8) biopsy samples were subjected to gene expression profiling using the NanoString® Technologies nCounter PanCancer Immune Profiling Panel. Multiplex immuno...
Compared with de novo BP controls, BP-irAE samples exhibited upregulation of 30 mRNA transcripts (p < 0.025), including toll-like receptor 4 (TLR4) and genes associated with complement activation, and...
BP-irAE exhibited activation of the TLR4/complement-driven classical innate immune response pathway, with dermal T...
(1) Background: It is our purpose to identify the differences in the changes in Complement C5a receptor 1 (C5aR1) levels showing the degree of inflammation at onset and Immunoglobulin G (IgG) levels s...
It is controversial whether all donor-specific antibodies (DSA) detected by the solid-phase single antigen bead (SAB) assay negatively affect kidney transplantation outcomes. The study aimed to evalua...
From the historical cohort of living donor recipients transplanted between 2014 and 2018 at our center (n = 82), 55 patients met the inclusion criteria, namely: these patients were > 18 years old with...
In the studied cohort, DSA-positive, NDSA reactive, and anti-HLA negative recipients constituted 33%, 36%, and 31% of 55 patients, respectively. Non-routinely considered pre-transplant HLA-DQ, -DP, an...
Our 3-year follow-up of patients with low pre-transplant DSA found no association with a deterioration in graft function and worse graft survival. Furthermore, we did not observe an increase in AMR in...
Following a request from the European Commission, the GMO Panel assessed additional information related to the application for authorisation of food and feed containing, consisting of and produced fro...
Diffuse intrinsic pontine glioma (DIPG) and paediatric high-grade glioma (pHGG) are aggressive glial tumours, for which conventional treatment modalities fall short. Dendritic cell (DC)-based immunoth...
10 paediatric patients with newly diagnosed or pretreated HGG or DIPG were treated according to the trial protocol. The trial protocol consists of leukapheresis of mononuclear cells, the manufacturing...
The ethics committee of the Antwerp University Hospital and the University of Antwerp granted ethics approval. Results of the clinical trial will be shared through publication in a peer-reviewed journ...
NCT04911621....
Neutrophil extracellular traps (NETs) being one of the predominant activities of neutrophils has become its key defense mechanism owing to its extensive role in inflammation and infection. However, th...
The validation of the transcriptomic data for C5aR1 and LTB4R1 was done using quantitative real time PCR. Pharmacological inhibition of C5aR1 and LTB4R1 using W-54011 and LY223982 on neutrophils of ad...
The expression of C5aR1 and LTB4R1, extracellular DNA, ROS and NET associated proteins (NE, CitH3, PAD4 and MPO) was notably increased upon NET induction in healthy adults and normal birth weight (NBW...
The C5aR1 and LTB4R1 signaling via Rap1a/B-Raf/ERK axis acts as a signal-relay mechanism to regulate NET formation in neutrophils. Further, C5aR1 and LTB4R1 signaling cascade along with NET-associated...
Postoperative pulmonary complications (PPCs) increase the hospital length of stay (LOS) and the cost of healthcare associated with surgical procedures. Strategies to reduce PPCs begin before surgery a...